Shionogi stock
Price history
+14.81% over the period1 year: from ¥2,718.50 (November 20, 2025) to ¥3,121.00 (November 20, 2026), +14.81%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | ¥3,121.00 |
| October 30, 2026 | ¥3,012.00 |
| September 30, 2026 | ¥2,870.50 |
| August 31, 2026 | ¥2,910.50 |
| July 31, 2026 | ¥2,908.50 |
| June 30, 2026 | ¥2,789.00 |
| May 29, 2026 | ¥3,000.00 |
| April 30, 2026 | ¥3,170.00 |
| March 31, 2026 | ¥3,469.00 |
| February 27, 2026 | ¥3,664.00 |
| January 30, 2026 | ¥3,174.00 |
| December 30, 2025 | ¥2,841.00 |
| November 28, 2025 | ¥2,680.50 |
| November 20, 2025 | ¥2,718.50 |
At a glance
The company
Research, develop, manufacture and distribute pharmaceuticals, diagnostic reagents, medical devices and consumer healthcare products
Latest results
Quarter to September 30, 2026 · EPS ¥25.66 (estimate ¥38.19)
Dividend
TickerLandia's take on Shionogi
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 13 vs a median of 15 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 11 vs 33 (−66%) in a group of 11.
- “Undervalued quality stocks” (Japan): No. 2 of 3.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−16.95% from the 52-week high
Analysts · 11 analysts
Average target¥3,386.36+8.50% vs. price
Buy 4 · Hold 7 · Sell 0 · Buy
TickerLandia Fingerprint: Shionogi
Compared with similar companies: high profitability, low risk, and strong momentum.
Financials and price compared with 39 companies in the drug manufacturers - specialty & generic industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Pricelow33
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 11.2 10 EV/EBITDA 11.4 26 Forward P/E 16.3 38 Price/book 1.52 19 Price/sales 4.17 70 Profitabilityhigh74
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 31.6% 83 ROA 5.9% 45 Gross margin 81.6% 88 Net margin 37.9% 94 ROE 15.2% 60 Earnings stabilityhigh62
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 2.8% 62 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 63 Growthaverage50
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +5.40% 38 Revenue growth (year over year) +65.30% 96 Earnings growth (year over year) −50.60% 16 Financial strengthhigh63
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −3.65 91 Interest coverage 324.7 94 Debt/equitycounts in reverse: lower means more financial strength 0.39 45 Current ratio 1.25 22 Dividendhigh65
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 27 years 80 Dividend yield 2.9% 85 Payout ratio 28.0% 31 Market momentumstrong72
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (6 months) +8.02% 63 Relative strength (3 months) +23.78% 89 1-year return +14.81% 66 Distance from 200-day average +1.52% 68 Risklow26
How much the price swings.
Metric Value Position in group Volatility (60 days) 30.3% 33 Maximum drawdown (12 months) 27.4% 35 Beta (1 year) 0.08 11
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Shionogi is cheaper than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2026), Shionogi's P/E today is 12.9, below the median of its last 10 fiscal years (15.3; between 9.62 and 22.5 from 2017 to 2026). Shionogi's P/E (trailing 12 months): 11.2, −66% against the median of a group of 11 similar companies (33.5).
Compared with 11 similar companies
| Metric | Shionogi | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 11.2 | Low | |
| Forward P/E | 16.3 | Low | |
| Operating margin | 31.6% | Middle | |
| ROE | 15.2% | Middle | |
| Debt/equity | 0.39 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Shionogi. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
¥187.07B
Latest quarter · Q3 2026
Net income
¥21.85B
Latest quarter · Q3 2026
Quarterly net margin
11.7%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- ¥2.66T
- P/E
- 11.2
- EPS
- ¥278.40
- Volume
- 2.99M
- Daily trading
- €53.1M
- Dividend yield
- 2.50%
How Shionogi is changing
All resultsRevenue grew 11.0% a year on average over the last 5 years
Operating margin fell from 37.3% to 32.2%
Profits turn into cash: free cash flow equal to 97% of net income
Returns
Shionogi returns with dividends
¥1,000 invested in Shionogi 5 years ago, on November 22, 2021, would be worth ¥1,335 today with dividends reinvested: +33.47% in total, +5.95% per year. On price alone it would be ¥1,158 (+15.84%).
| Period | Shionogi | Nikkei 225 | ¥1,000 becomes |
|---|---|---|---|
| 1 month | +4.78% | −11.92% | ¥1,048 |
| 6 months | +2.83% | −4.80% | ¥1,028 |
| Year to date | +9.86% | +12.11% | ¥1,099 |
| 1 year | +17.69% | +13.27% | ¥1,177 |
| 3 years | +46.04% | +69.03% | ¥1,460 |
| 5 years | +33.47% | +89.55% | ¥1,335 |
| 10 years | +116.47% | +211.70% | ¥2,165 |
Over the last 6 months it has done better than 34% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. Nikkei 225: price only. Calculate your investment
The chart in detail
Shionogi: technical analysis
Shionogi shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 14.8% below its all-time closing high (¥3,664.00, February 27, 2026).
- Trend
- No clear trend
- RSI (14 sessions)
- 55
- Between 30 and 70
- vs 200-session average
- +1.52%
Support and resistance
Price areas where Shionogi has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance¥3,225.33+3.34%3 touches, last on November 5, 2026
- Last price¥3,121.00
- Support¥3,089.00−1.03%3 touches, last on October 23, 2026
- Support¥3,014.50−3.41%3 touches, last on September 17, 2026
- Support¥2,944.00−5.67%4 touches, last on October 30, 2026
Volatility and risk
Over the last year it has moved little with the Nikkei 225.
- Beta (1 year) vs Nikkei 225
- 0.08
- Volatility (60 sessions, annualised)
- 30.3%
- Largest fall in the last year
- −27.37%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Shionogi: seasonality
Average monthly price change over 27 years
Over the last 27 years, the strongest month for Shionogi has been November: +2.99% on average, positive in 17 years out of 26. The weakest has been January: −2.86% on average, positive in 10 years out of 26.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −2.86% | −4.30% | 10 of 26 |
| February | +1.55% | +1.35% | 15 of 27 |
| March | +0.79% | −1.35% | 13 of 27 |
| April | +0.24% | −1.50% | 10 of 27 |
| May | +1.91% | +2.40% | 17 of 27 |
| June | +1.12% | −0.32% | 13 of 27 |
| July | −1.16% | −1.85% | 11 of 27 |
| August | +0.09% | +0.07% | 14 of 27 |
| September | +2.14% | +4.19% | 19 of 27 |
| October | +1.05% | +0.69% | 15 of 27 |
| November | +2.99% | +3.86% | 17 of 26 |
| December | +2.83% | +3.86% | 20 of 26 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Shionogi and its competitors
Shionogi & Co., Ltd. sells its pharmaceuticals, diagnostic reagents and medical devices in Japan and internationally. Its business covers research, development, manufacture and distribution of these products, alongside a consumer healthcare business. The company also develops mucosal vaccines, manufactures investigational drugs, and offers contract research and testing services for experimental research, agricultural production materials and pharmaceutical engineering, as well as IT and marketing support for healthcare customers.
- Headquarters
- Kita, Japan
- Employees
- 6,223
- Founded
- 1878
- Chief executive
- Isao Teshirogi
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Shionogi4507 | $16.75B | 31.6% | 11.2 | +2.83% |
| PharmaEssentia6446 | $15.94B | 38.4% | 74.1 | +54.65% |
| Yunnan Baiyao Group000538 | $15.07B | 11.2% | 19.4 | +11.07% |
| Torrent PharmaceuticalsTORNTPHARM | $19.25B | 22.2% | 79.2 | +5.88% |
| Laurus LabsLAURUSLABS | $14.13B | 24.1% | 97.8 | +68.58% |
| Zydus LifesciencesZYDUSLIFE | $12.92B | 17.2% | 28.7 | +15.29% |
Same industry or related industries, similar size. Compare Shionogi with its competitors · Full profile
